Ieq Capital, LLC Kodiak Sciences Inc. Transaction History

Ieq Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$7.09 - $89.45 $59,449 - $750,038	-8,385 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$80.85 - $128.49 $1,697 - $2,698	-21 Reduced 0.25%	8,385 $711,000
Q3 2021 Nov 09, 2021	BUY	$81.97 - $106.94 $1,721 - $2,245	21 Added 0.25%	8,406 $807,000
Q1 2021 May 04, 2021	BUY	$110.45 - $164.47 $926,123 - $1.38 Million	8,385 New	8,385 $951,000
Q4 2020 Feb 03, 2021	SELL	$60.78 - $154.03 $509,640 - $1.29 Million	-8,385 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$38.18 - $73.95 $320,139 - $620,070	8,385 New	8,385 $400,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $450M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ieq Capital, LLC with notifications on news.